301089 fundamentals
Key facts
Tuoxin Pharmaceutical Group Co., Ltd. engages in the research, development, production and sale of chemical synthetic biological fermented nucleoside APIs and pharmaceutical intermediates. It offers series of nucleoside (nucleotide) products including pyrimidine series, purine series, nucleotide series and nucleoside series, including citicoline sodium, ribavirin, inosine, cytosine, 5-fluorocytosine, cytidine and other raw materials and pharmaceutical intermediates. The company's products mainly covering antiviral, anti-tumor and nervous system medicine n terms of production management system. Xinxiang Tuoxin Pharmaceutical was founded on August 2, 2001 and is headquartered in Xinxiang, China.
Valuation
Fundamental metrics to determine fair value of the stock
Growth and Profitability
Company’s recent performance and margins
Dividends
Dividend yield, history and sustainability
Financial health
Financial position and solvency of the company